about
Recent advances in the diagnosis and management of migraineButterbur root extract and music therapy in the prevention of childhood migraine: an explorative study.Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding.Primary headache disorders and neuro-ophthalmologic manifestations.A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.Comparison of the effects of dietary factors in the management and prophylaxis of migraine.The prophylactic treatment of chronic daily headache.New developments in migraine prophylaxis.Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.Breastfeeding and migraine drugs.Prophylactic treatment of migraine by GPs: a qualitative study.Migraine treatment throughout the lifecycle.Patient outcome in migraine prophylaxis: the role of psychopharmacological agentsThe acute and preventative treatment of episodic migraine.Migraine: new treatment options from molecular biology.Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification.Hypoxia facilitates neurogenic dural plasma protein extravasation in mice: a novel animal model for migraine pathophysiologyTreatment of headaches with botulinum toxin.Biomarkers in migraine: their promise, problems, and practical applications.The contribution of stress to the comorbidity of migraine and major depression: results from a prospective cohort study.Preventive treatment in migraine and the new US guidelinesTopiramate for migraine prophylaxis.Optimizing prophylactic treatment of migraine: Subtypes and patient matching.Prophylaxis of migraine: general principles and patient acceptance.CGRP and migraine: could PACAP play a role too?Reactive oxygen species induce procalcitonin expression in trigeminal ganglia gliaValproate semisodium ER for migraine and cluster headache prophylaxis.Episodic migraines in children: limited evidence on preventive pharmacological treatments.Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies.Drug safety and tolerability in prophylactic migraine treatment.Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update.The Use of Antiepileptics in Migraine Prophylaxis.Prophylaxis of migraine headaches with riboflavin: A systematic review.Chronic migraine: risk factors, mechanisms and treatment.Amitriptyline Dose and Treatment Outcomes in Specialty Headache Practice: A Retrospective Cohort Study.Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies.Migraines in Women: Current Evidence for Management of Episodic and Chronic Migraines.Flunarizine effects on oxidative stress in migraine patients.A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
P2860
Q24535949-F1DE948E-0DBA-4AB5-86A9-437BDAC18D1AQ30363133-BD88B823-B6C2-4124-A497-3E10D6DFD468Q30466408-05FC0FDE-BBCC-4985-8BBB-443E97BB59EBQ33408977-C036CDB9-1403-4063-A641-C68208A15811Q33702135-844848E8-F398-41BD-96C8-2749B58C6585Q34003508-DCB921D1-A65A-43B6-83B9-AA13C5E80A14Q34418342-FBBC72C3-535A-4460-8755-F062802FC9F5Q34583067-DA3DDB5C-15B2-4C37-B2CB-865C97841AA6Q35095175-02A70417-FE6C-40DC-B7E6-D9458DBE741BQ35187508-7E3D5D13-D4BE-4D44-A00C-1F856A71E044Q35250900-F91E5FE5-A07C-422D-BD95-F80FF5EEA716Q35845695-F416C77B-4217-43BA-AFBB-C20AD9AF1CDEQ36153372-21F62406-88EC-48B2-AD59-0E70A868F2CEQ36160565-79B52AF4-04BE-4D4F-AE57-DBFD8AB69C07Q36239483-B07A562E-8AB4-4712-BB96-6455FF65D923Q36257220-EB1E384B-290D-48A8-9BBD-F7A7BC2DC8CFQ36259763-68A2CF1C-4E29-443F-8517-A61FAA7CD48BQ36353546-0C23FE4B-1FB1-4799-B31E-8BC8129E2D2CQ36419558-F2FFE29F-6D48-43A4-B659-EBA74A2A2B75Q36546349-2E3DEF9F-A1CE-4415-BC80-F8E240F4FA37Q36730268-38A86269-BF7F-4526-958A-0034779AA375Q36873484-27FBE671-CA0D-40B5-895B-3B91039B43F6Q36979333-839BB8CD-86D0-47AB-9FAC-43BEA80B7FD2Q37052803-66C9C1D4-D6DE-4932-98E0-DE884A114686Q37106958-B4B562CB-2ADF-40C8-B0AB-A65095B7B8C8Q37384128-99609450-CB98-4953-A87A-727A77011E99Q37627012-D5B51E56-B127-4636-B21D-6F8F9F77E99AQ37713736-0E529A5F-8079-4251-9B6A-A71AD512D203Q38113395-3029D686-0F03-46C6-B875-80E04C45679EQ38130336-41F9E4C6-D4DF-401A-8F0A-3488775838F9Q38353242-68BD2510-4B26-48EA-8E27-DC2490C31E3AQ38676482-72C89AF3-F6E1-49E9-B033-81CA5966AA40Q38758229-C3C5CAF7-1067-4798-A16B-7911B43F04CBQ38796523-AAF28D7E-F141-4EA2-9095-99EE5E26C501Q38889450-4760CA97-4BCC-4233-8C34-1D9394637D78Q38989288-7B3FA5AF-7BFD-491F-B760-389C873204D7Q39026796-D3732902-4771-4542-A233-3DDC89FD63EBQ39340622-3FB59BC6-E7FD-410E-8E31-84DF8D905E06Q39379591-31FB893E-C2FA-4B23-BB46-6D3DE6D626ECQ41571135-9C966A6A-8E73-4415-8794-9D54D0C75ECB
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Migraine: preventive treatment.
@ast
Migraine: preventive treatment.
@en
Migraine: preventive treatment.
@nl
type
label
Migraine: preventive treatment.
@ast
Migraine: preventive treatment.
@en
Migraine: preventive treatment.
@nl
prefLabel
Migraine: preventive treatment.
@ast
Migraine: preventive treatment.
@en
Migraine: preventive treatment.
@nl
P2860
P1433
P1476
Migraine: preventive treatment.
@en
P2093
S D Silberstein
P2860
P304
P356
10.1046/J.1468-2982.2002.00386.X
P407
P577
2002-09-01T00:00:00Z